Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci

R. E. Bryant; J. A. Mazza; E. M. Gardner

doi:10.1007/BF02018206

Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci

R. E. Bryant, J. A. Mazza, E. M. Gardner

Infectious Diseases

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

The antistaphylococcal activity of LY146032 was tested in human pus in vitro and in a murine abscess model in vivo. The drug was not degraded by pus containingΒlactamase and had equally good or better activity than nafcillin or vancomycin againstStaphylococcus aureus or Staphylococcus epidermidisin vitro and in vivo. Its activity was slightly enhanced when used in combination with rifampin and tobramycin.

Original language	English (US)
Pages (from-to)	186-188
Number of pages	3
Journal	European Journal of Clinical Microbiology
Volume	6
Issue number	2
DOIs	https://doi.org/10.1007/BF02018206
State	Published - Apr 1987

ASJC Scopus subject areas

Microbiology
Microbiology (medical)

Access to Document

10.1007/BF02018206

Cite this

@article{c8bcccdd9f584432a5fe92967b92736e,

title = "Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci",

abstract = "The antistaphylococcal activity of LY146032 was tested in human pus in vitro and in a murine abscess model in vivo. The drug was not degraded by pus containingΒlactamase and had equally good or better activity than nafcillin or vancomycin againstStaphylococcus aureus or Staphylococcus epidermidisin vitro and in vivo. Its activity was slightly enhanced when used in combination with rifampin and tobramycin.",

author = "Bryant, {R. E.} and Mazza, {J. A.} and Gardner, {E. M.}",

year = "1987",

month = apr,

doi = "10.1007/BF02018206",

language = "English (US)",

volume = "6",

pages = "186--188",

journal = "European Journal of Clinical Microbiology",

issn = "0722-2211",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci

AU - Bryant, R. E.

AU - Mazza, J. A.

AU - Gardner, E. M.

PY - 1987/4

Y1 - 1987/4

N2 - The antistaphylococcal activity of LY146032 was tested in human pus in vitro and in a murine abscess model in vivo. The drug was not degraded by pus containingΒlactamase and had equally good or better activity than nafcillin or vancomycin againstStaphylococcus aureus or Staphylococcus epidermidisin vitro and in vivo. Its activity was slightly enhanced when used in combination with rifampin and tobramycin.

AB - The antistaphylococcal activity of LY146032 was tested in human pus in vitro and in a murine abscess model in vivo. The drug was not degraded by pus containingΒlactamase and had equally good or better activity than nafcillin or vancomycin againstStaphylococcus aureus or Staphylococcus epidermidisin vitro and in vivo. Its activity was slightly enhanced when used in combination with rifampin and tobramycin.

UR - http://www.scopus.com/inward/record.url?scp=0023203853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023203853&partnerID=8YFLogxK

U2 - 10.1007/BF02018206

DO - 10.1007/BF02018206

M3 - Article

C2 - 3036500

AN - SCOPUS:0023203853

SN - 0722-2211

VL - 6

SP - 186

EP - 188

JO - European Journal of Clinical Microbiology

JF - European Journal of Clinical Microbiology

IS - 2

ER -

Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this